US03969T1097
US03969T1097
Arcturus Therapeutics Holdings
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 67.221.000 | 138.389.000 | 51.4% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 143.481.000 | 234.058.000 | 38.7% | |
| Operating Income | -76.260.000 | -95.669.000 | 20.3% |
| Pretax Income | -65.783.000 | -80.945.000 | 18.7% |
| Net Income Common Stockholders | -65.783.000 | -80.941.000 | 18.7% |
| -- | -- | -- | |
| -- | -- | -- |